Everand Logo

Welcome to Everand!

  • STAT

    Kaleo, maker of $4,100 overdose antidote, authorizes a generic version for just $178

    The drug maker Kaleo was charging $4,100 for a two-pack of an opioid overdose reversal device. After an outcry, it’s authorizing a generic for a fraction of the price.
    by Lev Facher Dec 12, 2018 2 minutes
    The auto-injector Evzio

    WASHINGTON — A month after the drug maker Kaleo came under fire from lawmakers and public-health advocates for charging $4,100 for a device that reverses overdoses, the company has announced it will introduce a generic version for a small fraction of the price.

    The company announced Wednesday it has authorized its subsidiary IJ Therapeutics to produce

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
    A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
    STAT1 min read
    USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
    With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
    Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.

    Related Books & Audiobooks